James Worden
Pain Medicine · Naples, FLNPI 1760420665
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 148 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,555 and has fallen 99.1% since, to $14 in 2024.
Across 148 payments — averaging $25.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$495
- Abbott$437
- Nevro Corp.$342
- Scilex Pharmaceuticals Inc.$324
- Teva Pharmaceuticals USA, Inc.$269
- Biodelivery Sciences International, Inc.$222
- plus $2K from 20 others
What the payments were for
- Food & beverage$3,837100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 22 | $495 |
| Abbott | 8 | $437 |
| Nevro Corp. | 7 | $342 |
| Scilex Pharmaceuticals Inc. | 19 | $324 |
| Teva Pharmaceuticals USA, Inc. | 11 | $269 |
| Biodelivery Sciences International, Inc. | 19 | $222 |
| AbbVie(2 entities) | 4 | $211 |
| Pfizer | 10 | $205 |
| Biohaven Pharmaceuticals, Inc. | 5 | $180 |
| Medtronic(3 entities) | 4 | $162 |
| Nalu Medical, Inc. | 1 | $153 |
| Daiichi Sankyo Inc. | 3 | $147 |
| Relievant Medsystems, Inc. | 1 | $140 |
| Amgen(2 entities) | 7 | $109 |
| Pacira Therapeutics, Inc. | 5 | $98 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Redhill Biopharma Inc. | 3 | $45 |
| Novartis | 2 | $38 |
| Arbor Pharmaceuticals, Inc. | 2 | $35 |
| Boston Scientific | 2 | $28 |
| Sentynl Therapeutics, Inc. | 2 | $24 |
| Tersera Therapeutics LLC | 1 | $24 |
| Pernix Therapeutics Holdings, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
| Fidia Pharma USA Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$560
- Proclaim Family of SCS IPGs$266
- Nalu Neurostimulation System$153
- UBRELVY$150
- Omnia$142
- AJOVY$140
- Senza Spinal Cord Stimulation System$123
- Morphabond ER$121
- NURTEC ODT$112
How this compares
$3,837 in reported general payments places this provider in the 60th percentile of 596 pain medicine providers in Florida.
Other pain medicine in Naples
- Joseph PergolizziNaples$333K
- Jeffrey GudinMiami$356K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
- Mark-Friedrich HurdleJacksonville$140K
- Rodolfo GariTampa$120K
- Stephen PylesOcala$115K
- Orlando FloreteJacksonville$86K
- Michael GreeneMiddleburg$73K
- Nicholas BremerFernandina Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.